Invention Grant
- Patent Title: Heterocyclic compounds for the inhibition of PASK
-
Application No.: US15010619Application Date: 2016-01-29
-
Publication No.: US11191765B2Publication Date: 2021-12-07
- Inventor: John McCall , Robert C. Kelly , Donna L. Romero
- Applicant: BioEnergenix LLC
- Applicant Address: US CA San Francisco
- Assignee: BioEnergenix LLC
- Current Assignee: BioEnergenix LLC
- Current Assignee Address: US CA San Francisco
- Agent Dennis A. Bennett; Brock Levin
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P3/10 ; A61P9/00 ; C07D487/04
Abstract:
Disclosed herein are new heterocyclic compounds and compositions having structural Formula (I) and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Public/Granted literature
- US20160235755A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK Public/Granted day:2016-08-18
Information query
IPC分类:
